surmount study tirzepatide Was Associated with Improved Health-Related Quality of Life in Adults with Obesity or Overweight and Type 2 Diabetes: Results from the Phase 3 SURMOUNT-2 Trial SURMOUNT-1 (NEJM 2022) tested tirzepatide
Pay in 4 interest-free payments of $6.23 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 25 - Sep 30


00656-2/asset/35b48abc-e313-46be-9a87-b6727032b3d4/main.assets/gr1_lrg.jpg)



















